Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02743858 · ClinicalTrials.gov registry record
Lymphedema Surveillance Study
A clinical trial of Breast Cancer and Lymphedema, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 1,250
- Enrollment target
- 7
- Study locations
NCT02743858 is a study of Breast Cancer and Lymphedema that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,250 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (55% lower). The trial reports 7 study locations across 2 states.
The verdict
NCT02743858, a study of Breast Cancer and Lymphedema, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 1,250 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is being done to find out how many women develop lymphedema after an axillary lymph node dissection. The investigators also want to look for reasons why some women get lymphedema and others don't. Specifically, the investigators want to do tests on the breast tissue that is removed at the time of surgery to see if they can identify inflammation in the breast tissue, which may increase a woman's risk for lymphedema. The investigators will also ask the patient to answer questions to see how much their quality of life is affected by lymphedema, and whether this study can help women by detecting lymphedema earlier.
Conditions Studied
Interventions
- OTHER Bilateral arm measurements
- OTHER Body mass index (BMI)
- BEHAVIORAL Quality of Life Questionnaire
- OTHER Blood draw
Study Locations (7)
New York
- Memorial Sloan Kettering Commack (Consent only) - Commack
- Memorial Sloan Kettering Westchester (Consent only) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Consent only) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent only) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent only) - Middletown
- Memorial Sloan Kettering Bergen (Consent only) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,250 participants |
| Start Date | 2016-04 |
| Est. Completion | 2026-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02743858
The ClinicalTrials.gov registry entry for NCT02743858 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (55% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Bilateral arm measurements is the first listed.
NCT02743858 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT02743858 about?
NCT02743858 is a clinical study titled "Lymphedema Surveillance Study". This study is being done to find out how many women develop lymphedema after an axillary lymph node dissection. The investigators also want to look for reasons why some women get lymphedema and others don't. Specifically, the investigators want to do tests on the breast tissue that is removed at the...
What is the current status of trial NCT02743858?
This trial is currently recruiting. The enrollment target is 1,250 participants. The study started on 2016-04. Estimated completion is 2026-04.
What conditions does trial NCT02743858 study?
This clinical trial studies the following conditions: Breast Cancer, Lymphedema.
What interventions are being tested in trial NCT02743858?
The interventions under investigation include: Bilateral arm measurements (OTHER), Body mass index (BMI) (OTHER), Quality of Life Questionnaire (BEHAVIORAL), Blood draw (OTHER).
Who is sponsoring clinical trial NCT02743858?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02743858 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.